Continuous Hyperfractionated Accelerated Radiotherapy (CHART) and Non-conventionally Fractionated Radiotherapy in the Treatment of Non-small Cell Lung Cancer: a Review and Consideration of Future Directions

被引:11
|
作者
Hatton, M. Q. F. [1 ]
Martin, J. E. [1 ]
机构
[1] Weston Pk Hosp, Dept Clin Oncol, Sheffield S10 2SJ, S Yorkshire, England
关键词
Accelerated radiotherapy; CHART; chemoradiotherapy; non-small cell lung cancer; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; THERAPY-ONCOLOGY-GROUP; STEREOTACTIC BODY RADIOTHERAPY; HIGH-DOSE RADIATION; INDUCTION CHEMOTHERAPY; TUMOR-CONTROL; PHASE-I/II; HYPOFRACTIONATED RADIOTHERAPY; CLINICAL-OUTCOMES; MULTICENTER TRIAL;
D O I
10.1016/j.clon.2010.03.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
There is a well-established role for radiation treatment in the management of non-small cell lung cancer As a single modality, it is indicated as a radical treatment option for patients deemed unsuitable for chemotherapy with inoperable locoregional disease or who decline surgery In this patient group, the evidence shows advantages for accelerated treatment regimes, e g continuous hyperfractionated accelerated radiotherapy (CHART) Research efforts should be directed towards close escalation with the application of the new technologies available The multi-modality approach of chemoradiotherapy is established in the radical treatment of non-small cell lung cancer in those who are inoperable, radically treatable and Fit enough to receive chemotherapy How best these two modalities ale combined remains unclear, and the combination of CHART and other non-conventionally fractionated radiotherapy schedules with chemotherapy and targeted agents is another potentially productive research area (C) 2010 The Royal College of Radiologists Published by Elsevier Ltd All rights reserved
引用
收藏
页码:356 / 364
页数:9
相关论文
共 50 条
  • [21] Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres
    Sanganalmath, P.
    Lester, J. E.
    Bradshaw, A. G.
    Das, T.
    Esler, C.
    Roy, A. E. F.
    Toy, E.
    Lester, J. F.
    Button, M.
    Wilson, P.
    Comins, C.
    Atherton, P.
    Pickles, R.
    Foweraker, K.
    Walker, G. A.
    Keni, M.
    Hatton, M. Q.
    CLINICAL ONCOLOGY, 2018, 30 (03) : 144 - 150
  • [22] Sequential chemotherapy and continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC): experience from nine UK centres
    Bradshaw, A. G.
    Lester, J. E.
    Das, T.
    Esler, C.
    Branagan, J.
    Roy, A. E. F.
    Toy, E. W.
    Alip, A.
    Lester, J. F.
    Williams, R.
    Kinsman, J.
    Comins, C.
    Atherton, P.
    Knox, C.
    Morgan, S.
    Walker, G. A.
    Hatton, M. Q.
    LUNG CANCER, 2014, 83 : S54 - S54
  • [23] Treatment of Non-small Cell Lung Cancer (NSCLC) Using Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART): the Weston Park Hospital Experience 2005-2010
    Lester, J. E.
    Das, T.
    Din, O. S.
    Hatton, M. Q.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S43 - S44
  • [24] Survival following treatment of non-small cell lung cancer (NSCLC) using continuous hyperfractionated accelerated radiotherapy (CHART): A single-centre retrospective analysis
    Ayre, G.
    Casswell, G.
    Comins, C.
    Falk, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S108 - S109
  • [25] Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer
    Zwitter, Mayaz
    Kovac, Vijem
    Smrdel, Uros
    Strojan, Primoz
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (07) : 662 - 666
  • [26] Individualized hypo/hyperfractionated radiotherapy for non-small cell lung cancer
    Chang, Joe Y.
    De Ruysscher, Dirk
    JOURNAL OF THORACIC DISEASE, 2014, 6 (04) : 285 - 286
  • [27] Neoadjuvant chemotherapy & continuous hyperfractionated accelerated radiotherapy, weekend less (CHARTWEL) in non-small cell lung cancer.
    Sibtain, A
    Rojas, A
    Lyn, BE
    Hoskin, PJ
    Shah, N
    Saunders, MI
    BRITISH JOURNAL OF CANCER, 1999, 80 : 15 - 15
  • [28] Continuous hyperfractionated accelerated radiotherapy (CHART) for patients with inoperable non-small cell lung Cancer (NSCLC): 10 year experience of the Exeter Oncology Centre
    Alip, A.
    Toy, E. W.
    LUNG CANCER, 2011, 71 : S35 - S35
  • [29] The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer
    Georg Holgersson
    Michael Bergqvist
    Jan Nyman
    Even Hoye
    Martin Helsing
    Signe Friesland
    Margareta Holgersson
    Lars Ekberg
    Charlotte Mörth
    Simon Ekman
    Thomas Blystad
    Sven-Börje Ewers
    Britta Löden
    Roger Henriksson
    Stefan Bergström
    Medical Oncology, 2013, 30
  • [30] Hyperfractionated radiotherapy for clinical stage II non-small cell lung cancer
    Jeremic, B
    Shibamoto, Y
    Acimovic, L
    Milisavljevic, S
    RADIOTHERAPY AND ONCOLOGY, 1999, 51 (02) : 141 - 145